I have written about your question, based on the GHTF Risk Management guidance
SG3/N15 ISO 14971 has had a requirement for traceability since the first edition. It has not been well implemented though. But Annex C in GHTF SG3/N15 had a good start with the requirement, but I expanded that in my article in
AAMI Horizons Spring 2015 issue
Documenting Medical Device Risk Management through the Risk Traceability SummaryThe article also discusses why FMEA, a reliability tool and not a safety tool, does not, by itself, meet the requirements of ISO 14971 (Now Clause 5.4 of the 2019 standard). FMEA does not address hazards caused all faults, since it is a single fault tool. FMEA does not address the requirement for normal condition hazards. So be cautious in the use of the tool, which does have its good points.
Also you should look at ISO TR 24971:2020 for information on traceability in 4.5 and the use of international standards in risk management in Annex E. This is a real time saver, as you can, when you use standards, and you implement them as required in the international standard, you can directly document this activity, skipping some lengthy meetings discussing hazards that have already been covered by the standard.
Hopefully this has been helpful.
------------------------------
Edwin Bills MEd, CQA, RAC, BSc, CQE, ASQ
Principal Consultant and Member, ISO TC 210 JWG1
Overland Park KS
United States
elb@edwinbillsconsultant.comPrincipal Consultant
------------------------------
Original Message:
Sent: 26-Nov-2021 12:41
From: Anonymous Member
Subject: Risk management file solely based on FMEAs and compliance to EU MDR requirements
This message was posted by a user wishing to remain anonymous
Dear all,
Would it be acceptable to build a risk management file using only Design, process and usability FMEAs and still be compliant to ISO 14971:2019?
If yes, could you please provide a guidance on how to do so?
If no, what would be the best strategy to use? (apart from redoing the risk Management from scratch).
Please note that the product is a class IIb and is already on the market for 3 years and is therefore in the transition period.
Note that questionnaire from Appendix A of TR24971 has been filled in.
Thank you,
Best regards,